For most of June there was only one thing the investment community was focused on: the initial public offering (IPO) of SpaceX, Elon Musk's space exploration and artificial intelligence (AI) company.

Goldman Sachs earlier downgraded SkyWest to Neutral from Buy, citing higher downside risk to block hour production as partner airlines plan slower capacity growth than previously expected, even as the ...

Rolls-Royce Holdings (LSE:RR.) has refreshed its board with new directors drawn from major global aerospace and energy companies. The company has agreed a partnership with Bombardier to deploy an ...

Advanced Energy Industries has nearly tripled investors' money over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the ...

Analysts have lifted their fair value estimate for QuickLogic to about US$23.67 per share from roughly US$9.67, a sharp reset that stands out even in a volatile small cap space. Much of this shift is ...

Is SARO a good stock to buy? We came across a bullish thesis on StandardAero, Inc. on Valueinvestorsclub.com by Astor. In this article, we will summarize the bulls’ thesis on SARO. StandardAero, ...

Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) rose by 5.3% on Tuesday after Stifel reiterated its Buy rating and $125 price target on the stock, with the move also supported by a broader ...

The updated Teradyne model now points to a higher assessed fair value, rising from US$374.82 to US$416.65, an 11% move that has sharpened attention on where analysts see the stock settling. That shift ...

Ulta Beauty stock has fallen away from its recent highs and is now trading at a level where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while the broader ...

Boliden and Nexa Resources (NYSE:NEXA) have confirmed that they are in ongoing discussions regarding a potential acquisition. The talks involve Nexa's majority shareholder, Votorantim S.A., and relate ...

Lenovo Group's 137% YTD surge, affordable valuation, AI server pipeline and growth projections make the stock a compelling portfolio addition.

Moderna (NASDAQ: MRNA) stock jumped about 10% on Thursday to $79.76 -- a fresh high for the year and the latest leg of a run that has carried shares up more than 70% in a month. The catalyst? In June, ...